SONOTARG LIMITED

Company number NI656568 ·

Active

The most recent accounts indicate this company is dormant and not trading.

Free AI analysis

Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.

Get the analysis

Shareholders' funds

£75

Balance sheet as at 2019-10-31

View full accounts →

Overview

Company type
Private Limited Company
Incorporated
2018-10-23
Registered office
Victoria House, 15-17 Gloucester Street, Belfast, BT1 4LS
Postcode
BT1 4LS
Capital
202 GBP
Accounts category
Total Exemption Full

Accounts

Last made up to
2025-10-31
Next due by
2027-07-31
Financial year end
31 October

Confirmation statement

Last statement dated
2025-10-23
Next due by
2026-11-06
View filing history →

Nature of business (SIC)

  • 72110 Research and experimental development on biotechnology

Officers 6 current · 5 resigned

Appointed 2025-08-31
Appointed 2022-04-05
Appointed 2022-04-05
Appointed 2021-06-01
Appointed 2018-10-23

View all officers and resignations →

Group structure 2 subsidiaries

Controlled by INNOVATION ULSTER LIMITED — since 2022-04-05

From persons-with-significant-control filings on the public register.

Contact details

Website
sonotarg.com
Phone
+44 2870449889

SonoTarg has developed a new approach to cancer therapy that minimises the adverse effects associated with conventional chemotherapy.

Among its peers

Among the oldest 25%

of 60 similar companies in BT, trading since 2018

87 companies are registered at this postcode →

Competitors Belfast

This company ranks 22 among research and experimental development on biotechnology in Belfast.

Full league table →

The class of 2018

36%

of the 439 companies in this sector incorporated in 2018 are still active today; 60% have since been dissolved.

A fact about the year, not a forecast for this company.